Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Vet Res ; 20(1): 127, 2024 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-38561720

RESUMO

BACKGROUND: Pseudomonas putida is a pathogenic bacterium that induces great losses in fishes, including Nile tilapia (Oreochromis niloticus). Currently, the application of nanomaterials in aquaculture practices has gained more success as it endows promising results in therapies compared to traditional protocols. OBJECTIVE: Therefore, the current perspective is considered the first report to assess the anti-bacterial efficacy of titanium dioxide nanogel (TDNG) against Pseudomonas putida (P. putida) in Nile tilapia. METHODS: The fish (n = 200; average body weight: 47.50±1.32 g) were allocated into four random groups (control, TDNG, P. putida, and TDNG + P. putida), where 0.9 mg/L of TDNG was applied as bath treatment for ten days. RESULTS: Outcomes revealed that P. putida infection caused ethological alterations (surfacing, abnormal movement, and aggression) and depression of immune-antioxidant variables (complement 3, lysozyme activity, total antioxidant capacity, superoxide dismutase, and reduced glutathione content). Additionally, a substantial elevation in hepatorenal biomarkers (aspartate and alanine aminotransferases and creatinine) with clear histopathological changes and immuno-histochemical alterations (very weak BCL-2 and potent caspase-3 immuno-expressions) were seen. Surprisingly, treating P. putida-infected fish with TDNG improved these variables and obvious restoration of the tissue architectures. CONCLUSION: Overall, this report encompasses the key role of TDNG as an anti-bacterial agent for controlling P. putida infection and improving the health status of Nile tilapia.


Assuntos
Ciclídeos , Doenças dos Peixes , Polietilenoglicóis , Polietilenoimina , Pseudomonas putida , Titânio , Animais , Antioxidantes , Nanogéis , Dieta , Suplementos Nutricionais , Ração Animal/análise , Doenças dos Peixes/tratamento farmacológico , Doenças dos Peixes/microbiologia
2.
Fish Shellfish Immunol ; 144: 109287, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38092091

RESUMO

Bacterial infection is considered one of the major issues in fish culturing that results in economic losses. Metal nanoparticles are a cutting-edge and effective disease management and preventive strategy because of their antibacterial ability. In this investigation, the selenium nanoparticles were prepared by a biological method using Nelumbo nucifera leaves extract. The in-vitro antibacterial activity of N. nucifera synthesized selenium nanoparticles (NN-SeNPs) was tested against Aeromonas veronii. A treatment assay was conducted on 210 Oreochromis niloticus (average body weight: 27 ± 2.00 g). A preliminary approach was conducted on 90 fish for determination of the therapeutic concentration of NN-SeNPs which was found to be 4 mg/L. Fish (n = 120) were categorized into four groups for 10 days; G1 (control) and G2 (NN-SeNPs) were non-challenged and treated with 0 and 4 mg/L NN-SeNPs, respectively. While, G3 and G4 were infected with 2 × 106 CFU/mL of A. veronii and treated with 0 and 4 mg/L NN-SeNPs, respectively. NN-SeNPs exhibited an inhibition zone against A. veronii with a diameter of 16 ± 1.25 mm. The A. veronii infection increased the hepato-renal biomarkers (alanine and aspartate aminotransferases and creatinine) than the control group. An oxidative stress was the consequence of A. veronii infection (higher malondialdehyde and hydrogen peroxide levels with lower glutathione peroxidase superoxide, dismutase, and catalase activity). A. veronii infection resulted in lower immunological biomarker values (immunoglobulin M, lysozyme, and complement 3) with higher expression of the inflammatory cytokines (interleukin-1ß and tumor necrosis factor-ɑ) as well as lower expression of the anti-inflammatory cytokines (interleukin-10 and transforming growth factor-ß). Therapeutic application with 4 mg/L NN-SeNPs prevented the disease progression; and modulated the hepato-renal function disruptions, oxidant-immune dysfunction, as well as the pro/anti-inflammatory cytokines pathway in the A. veronii-infected fish. These findings suggest that NN-SeNPs, employed as a water therapy, can safeguard fish from the harmful effects of A. veronii and serve as a promising antibacterial agent for sustainable aquaculture.


Assuntos
Ciclídeos , Doenças dos Peixes , Nanopartículas Metálicas , Nanopartículas , Nelumbo , Selênio , Animais , Antioxidantes/metabolismo , Selênio/farmacologia , Selênio/metabolismo , Aeromonas veronii , Citocinas/metabolismo , Dieta , Anti-Inflamatórios/metabolismo , Antibacterianos/metabolismo , Ração Animal/análise
3.
Sci Rep ; 12(1): 19617, 2022 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-36380061

RESUMO

In the present work, the composite cross-linked were used to consolidate the dyed paper manuscripts. Nanocomposites of mesoporous silica nanoparticle (MPSNP)/polyvinyl alcohol (PVA) and cellulose nanofiber (CNF)/PVA, which have never been used before, have been evaluated for the consolidation process of the dyed paper manuscripts with madder extract. Three concentrations 1%, 3%, and 5% have been prepared. Analysis and investigation methods like scanning electron microscope (SEM), transmission electron microscope (TEM), dynamic light scattering analysis (DLS), X-Ray diffraction Analysis (XRD), atomic force microscope (AFM), Fourier transform infrared spectroscopy (FTIR) and total color difference (ΔE) by spectrophotometer have been used in order to characterize the prepared nano-sized composites and evaluate the treated dyed paper samples before and after the aging process. The results of surface morphology by SEM revealed the effectiveness of MPSNP/PVA core-shell nanocomposite at 5% in the consolidation process, where the improvement of properties of the aged dyed paper samples. The fibers of the treated paper became strong and appeared clearly. The result of ΔE measurements showed that the treated sample with MPSNP/PVA nanocomposite at 5% gave the lowest ΔE (5.22), while, the treated sample with CNF/PVA nanocomposite at 5% gave the highest ΔE value (11.66). Mechanical measurements (tensile strength and elongation) revealed the efficiency of MPSNP/PVA nanocomposite at 5% in the treatment of the aged dyed paper samples. The treated sample with the mentioned material gave tensile strength and elongation values of 84.8 N/nm2 and 1.736%, respectively. In contrast, the treated sample with CNF/PVA nanocomposite at 1% gave the lowest tensile strength and elongation values 38.2 N/nm2, and 1.166%, respectively. FTIR analysis revealed an increase was noticed in the CH2 stretching band (refers to the crystallinity of cellulose), where the intensity of the treated sample with MPSNP/PVA nanocomposite was at a 5% increase compared to the control sample. The FTIR results supported the results of mechanical measurements. The intensity of the CH2 stretching band, which refers to the crystallinity index of cellulose, was increased with the use of MPSNP/PVA nanocomposite at 3% and 5%, which explains the improvement in mechanical properties. This may be due to the nano-mineral particles, which improve the mechanical properties. Additionally, they reduce the effect of accelerated thermal aging on the cellulosic fibers and give them stability. The detailed analysis of analytical methods used for evaluation revealed the novelty of MPSNP/PVA nanocomposite, especially at 5%. It has a potential role in strengthening and improving different properties of the dyed paper manuscripts with madder extract.


Assuntos
Nanocompostos , Álcool de Polivinil , Álcool de Polivinil/química , Celulose/química , Dióxido de Silício/química , Corantes , Nanocompostos/química , Extratos Vegetais
4.
Bioorg Chem ; 127: 105927, 2022 10.
Artigo em Inglês | MEDLINE | ID: mdl-35868104

RESUMO

BACKGROUND: Nanoparticles are recently playing a potential role in improving drug uptake and the treatment of diseases. A variety of nanoparticles, such as selenium nanoparticles (SeNPs) and Silver nanoparticles (AgNPs) have been used as drug carriers in various ways for treatment of cancers and liver diseases. Our aim in this study is to investigate the ability of AgNPs and SeNPs to target and treat the viral and bacterial infection of liver in rats and cell lines. METHODS: For assessment of antioxidant activity of silver nanoparticles, six adult male albino rats were included in this study, liver slices were taken and assigned to 6 groups. Markers of hepatic functions, oxidative stress and inflammation in liver slices are carried out. While for assessment of antiviral activity of SeNPs, HBV-replicating human cell line HepG2 and normal human cell lines were used, hepatic and inflammatory alterations are determined through quantitative polymerase chain reaction (PCR) and comet assay techniques. RESULTS: The effect of Ag-NPs on interleukin-6 (IL-6) and tumor necrosis factor (TNF-α) levels were reduced in different treated groups with Ag-NPs compared with the control and diseased groups. On the other hand, SeNPs revealed significant alterations in the inflammatory markers as well as DNA damage in the treated HBV- human cell line HepG2 compared to the diseased ones. CONCLUSION: Silver nanoparticles have the ability for producing various hepatic alterations and can inhibit the proliferation of hepatic stellate cells (HSCs) in a dose and size dependent manner. On the other hand, SeNPs showed excellent selectivity towards viral cells in the HepG2 cell lines. Both Ag-NPs and SeNPs might be a promising drug design for treating viral and bacterial liver diseases.


Assuntos
Hepatopatias , Nanopartículas Metálicas , Nanopartículas , Selênio , Humanos , Masculino , Ratos , Antioxidantes/farmacologia , DNA , Hepatopatias/tratamento farmacológico , Nanotecnologia , Estresse Oxidativo , Selênio/farmacologia , Prata/farmacologia , Animais
5.
J Biochem Mol Toxicol ; 36(3): e22972, 2022 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-34964201

RESUMO

Nanoparticles are recently playing a potential role in improving drug uptake and the treatment of diseases. A variety of nanoparticles, such as selenium nanoparticles (SeNPs) and silver nanoparticles (AgNPs) have been used as drug carriers in various ways for treatment of cancers and liver diseases. Our aim in this study is to investigate the ability of AgNPs and SeNPs to target and treat the viral and bacterial infection of the liver in rats and cell lines. For assessment of antioxidant activity of AgNPs in rats with induced liver bacterial infection, six adult male albino rats were included in this study, liver slices were taken and assigned to 6 groups. Markers of hepatic functions, oxidative stress, and inflammation in liver slices are carried out. Although for assessment of antiviral activity of SeNPs, hepatitis B virus transfected (HBV)-replicating human cell line HepG2 and normal hepatocyte cells were used, hepatic and inflammatory alterations are determined through quantitative polymerase chain reaction and comet assay techniques. The effect of AgNPs on interleukin-6 and tumor necrosis factor levels were reduced in different treated groups with AgNPs compared with the control and diseased groups. On the other hand, SeNPs revealed significant alterations in the inflammatory markers as well as DNA damage in the treated HBV-human cell line HepG2 compared to the diseased ones. AgNPs have the ability for producing various hepatic alterations and can inhibit the proliferation of hepatic stellate cells (HSCs) in a dose and size-dependent manner. On the other hand, SeNPs showed excellent selectivity towards viral cells in the HepG2 cell lines. Both AgNPs and SeNPs might be promising drug designs for treating viral and bacterial liver diseases.


Assuntos
Infecções Bacterianas , Fragmentação do DNA/efeitos dos fármacos , Vírus da Hepatite B/metabolismo , Hepatite B , Nanopartículas Metálicas , Estresse Oxidativo/efeitos dos fármacos , Selênio , Prata , Animais , Infecções Bacterianas/tratamento farmacológico , Infecções Bacterianas/metabolismo , Células Hep G2 , Hepatite B/tratamento farmacológico , Hepatite B/metabolismo , Humanos , Masculino , Nanopartículas Metálicas/química , Nanopartículas Metálicas/uso terapêutico , Ratos , Selênio/química , Selênio/farmacologia , Prata/química , Prata/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA